Andreakos_Lab
@Andreakos_Lab
Followers
78
Following
38
Media
6
Statuses
33
Immunology Lab of the Centre for Clinical, Experimental Surgery and Translational Research of the Biomedical Research Foundation of the Academy of Athens.
Ελλάς
Joined April 2019
New study finds 24% of 42 doubly mRNA vaccinated patients with breakthrough #COVID19 with severe pneumonia had autoantibodies neutralizing type I IFN, suggesting these autoantibodies are a key player in life-threatening breakthroughs. @casanova_lab
https://t.co/81nowFxnZ9
1
52
114
The race is on to solve one of Covid’s greatest mysteries: why some people just can’t catch the virus even after many exposures. @megtirrell reports as researchers from around the world say they’re on a mission to figure it out.
11
32
88
Just published‼️ 🔗 https://t.co/aKdwbbQYXi
@VangelisAndrea1
nature.com
Nature Immunology - The molecular basis for type I interferon (IFN)-mediated immunopathology is unclear. New data now identify the cGAS–STING pathway as a major driver of pathological type I...
Andreakos discusses in @NatImmunol two new studies on how #SARS_CoV_2 infection triggers type I IFN-mediated immunopathology @VangelisAndrea1
https://t.co/djm2p3Sjtr
0
1
5
Our work at @NatImmunol showing an impaired antiviral immune response in #COVID-19 compared to #flu is out. Many thanks to all the team!
3
22
84
Beautiful work from Mila Prokunina @prokuninaolsson in @NatureGenet identifies a novel truncated ACE2 isoform that does not bind SARS-CoV-2 https://t.co/nXCUrOET5t. Congratulations Mila!
0
0
1
Untuned antiviral immunity in COVID-19 revealed by temporal type I/III interferon patterns and flu comparison
medrxiv.org
A central paradigm of immunity is that interferon (IFN) mediated antiviral responses precede the pro-inflammatory ones, optimizing host protection and minimizing collateral damage[1][1],[2][2]. Here,...
1
7
18
TO_AITION, a new EC-funded Consortium Dr. Andreakos is coordinating, kicks off in Athens. This aims at unwinding #immune-#metabolic causes of #cardiovascular disease-#depression multimorbidities. @CrownePlazaAth
https://t.co/gkQuzHWYup
#science #Athens #Greece
1
1
2
Severe asthma during childhood and adolescence: A longitudinal study,
0
9
22
B cells, plasma cells and antibody repertoires in the tumour microenvironment https://t.co/B2R6642Cgm
1
76
172
This is the one week of the year we don't release a new issue of Science Magazine. So, instead, enjoy this animated cover of our "Quality Control in the Cell" issue crafted by @ScienceVisuals. #CellBiology
5
191
578
In preparation for 2020, take a look back at the Immunity covers of 2019! We've got clocks, tea, #ImmunityCommunity, liver, EBV, & more! Thank you to all the scientists and illustrators that contributed to these beautiful and creative covers! ♥️ What's your favorite?
7
20
95
Targeting a protein called Helios could potentially serve as a future strategy to engineer T regulatory cell populations for treating #autoimmune diseases or transplant rejection, @im_mel_nology and fellow @UCSFMedicine researchers suggest: https://t.co/nGQq8gPsai
0
11
31
🎂 Happy birthday Marie! 152 years and still one of the most fascinating, inspirational scientists of all times. Give her a birthday present, share her story! #MSCA #NobelPrize #WomenInScience
1
203
377
Carotid artery imaging better predicts an initial cardiovascular event than Coronary artery imaging A recent study has revealed that carotid artery imaging more strongly predicts Atherosclerotic Cardiovascular Disease Score than Coronary Artery imaging. https://t.co/v1D0KhC5m3
0
1
1
Today is #WorldPhageDay! At @Cure_asthma we are investigating if #phagetherapy would control the #immune dysregulation of #asthma and eventually #cure it. More information: https://t.co/nK7bgTynpY
@umedlodz @eliavainstitute @EFA_Patients @OfficialUoM @SIAF_UZH @ExelixisRM
0
5
15
“#Phage use can help modulate respiratory #virome and #microbiome and can have important implications for #asthma management” Read the interview with Dr. @GeorgeGuibas, member of the Ethics Advisory Board of @Cure_asthma: https://t.co/q1ntYhT1aW
0
2
4